Panaceutics Nutrition Promotes Staton Noel to Chief Executive Officer to Lead Commercial Expansion

Panaceutics Nutrition Promotes Staton Noel to Chief Executive Officer to Lead Commercial Expansion

Panaceutics Nutrition Promotes Staton Noel to Chief Executive Officer to Lead Commercial Expansion

Personalized nutrition supplement provider names pharmaceutical industry veteran and Co-Founder of Panaceutics as CEO to continue to drive growth forward

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Panaceutics Nutrition, Inc, a personalized nutrition company that uses patented automated robotic blending and manufacturing technology, is pleased to announce Staton Noel as its Chief Executive Officer. As the Co-Founder and Chief Innovation Officer for Panaceutics Nutrition, Noel has played a significant leadership role in developing the company’s technology, building a strong client pipeline and capturing new revenue streams for the company. With over twenty client projects underway to launch new products plus two significant commercial launches in Q3 of 2022, Panaceutics Nutrition has tremendous forward potential and is poised for further growth in 2023.

Having 20 years of experience in biotechnology and pharmaceutical drug research and development, Noel is an established pioneer in personalized nutrition technology and delivery and is co-inventor on the 12 patents covering the personalization manufacturing enabling Panaceutics. He holds a BS in Biochemistry from North Carolina State University, an MS in Gerontology, and an MBA from the University of North Carolina at Greensboro, where he also spent five years as Director of the Office of Innovation Commercialization, managing and licensing intellectual property and negotiating complex inter-institutional agreements. Prior to co-founding Panaceutics Nutrition, Noel served as a molecular pharmacologist at GlaxoSmithKline, where he developed both broad technical knowledge and therapeutic expertise while leading multiple drug discovery projects. He has also authored multiple peer-reviewed scientific papers.

“I couldn’t be more excited to take on the role of CEO for Panaceutics,” said Noel. “We have experienced significant growth using our proprietary platform that is able to provide personalized supplement products at scale based on an individual’s data. In this post-pandemic world, our clients seek customized solutions and we are able to build those within minutes using our patented high-speed robotics manufacturing system. I am passionate about continuing to share our highest degree of personalization platform with more customers, including those seeking small, customized orders.”

In 2022 alone, Panaceutics launched a precision microbiome product, developed an on-demand personalized nutrition gel formula based on individuals’ biomarkers for nutrition gel provider HealthyCell, and was awarded a patent for a new format for nutrition bar production.

Former CEO Adam Monroe will continue to support the board and serve as an advisor to the company.

ABOUT Panaceutics Nutrition, Inc.

Founded in 2018, Panaceutics applies proprietary technology and science to produce customized nutritional products that can be personalized based on genetic and medical tests, preferences, and an individual’s unique selections, and then delivered directly to end consumers. Panaceutics’ unique automated robotic blending and manufacturing technology supports economical customization of nutrition products. The Panaceutics founders and executive team bring extensive experience in food and nutrition, pharmaceutical science, automation and robotics, manufacturing and supply chain management and entrepreneurial organizations.


Mark Friedman, Chief Financial Officer,